Correlation Between INmune Bio and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Cue Biopharma, you can compare the effects of market volatilities on INmune Bio and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Cue Biopharma.
Diversification Opportunities for INmune Bio and Cue Biopharma
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between INmune and Cue is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of INmune Bio i.e., INmune Bio and Cue Biopharma go up and down completely randomly.
Pair Corralation between INmune Bio and Cue Biopharma
Given the investment horizon of 90 days INmune Bio is expected to generate 0.5 times more return on investment than Cue Biopharma. However, INmune Bio is 2.0 times less risky than Cue Biopharma. It trades about -0.27 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.26 per unit of risk. If you would invest 617.00 in INmune Bio on August 29, 2024 and sell it today you would lose (129.00) from holding INmune Bio or give up 20.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
INmune Bio vs. Cue Biopharma
Performance |
| Timeline |
| INmune Bio |
| Cue Biopharma |
INmune Bio and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INmune Bio and Cue Biopharma
The main advantage of trading using opposite INmune Bio and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |